Triomics

Oncology-focused AI platform that reads longitudinal patient records to automate trial matching and chart abstraction at cancer centers.

Triomics, founded in 2021 and headquartered in New York, builds oncology-specific AI that reads the full longitudinal patient record — including unstructured notes — to support clinical trial matching, eligibility pre-screening, and chart abstraction. The company works with major academic cancer centers and raised a $22M Series B in May 2026. Its privacy policy documents how it handles HIPAA-regulated health data; Atlas found no vendor-held security certifications documented on its site.

Headquarters
New York, United States
Founded
2021
Deployment options
cloud
Website
https://www.triomics.com
LinkedIn
https://www.linkedin.com/company/triomics

Categories

AI Use Cases

  • Clinical Data Management
  • Patient Recruitment & Enrollment

Vendor Scorecard

50% — Partial coverage. Coverage score — how completely Atlas documents Triomics across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.

Compliance & Validation — Not documented by Atlas

Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?

Deployment & Hosting — Documented

cloud

Pricing Transparency — Not documented by Atlas

Ask the vendor: What is your pricing model, and what drives total cost of ownership?

Implementation & Onboarding — Not documented by Atlas

Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?

Organization & Role Fit — Documented

Mid-Size Biotech, Large Pharma, Academic / Research, Clinical Operations, Data Management, R&D Leadership

Solution Scope — Documented

Natural Language Processing, Patient Recruitment

Company Viability — Partially documented

Series B, Founded 2021

Always ask the vendor

Not captured in Atlas data — confirm directly. Excluded from the score above.

Data Rights & IP

Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?

Model Credibility & Explainability

Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?

Questions to Ask This Vendor

  • How is extraction and matching accuracy measured on our patient population and document types?
  • Which EHR systems can the platform ingest, and what does integration require?
  • What security certifications or third-party audits can you share under NDA?
  • Which cancer center deployments can serve as references for our use case?